ArrowMark Colorado Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,806,712
Closed -$78.2M 371
2021
Q3
$78.2M Sell
2,806,712
-73,407
-3% -$2.05M 0.61% 50
2021
Q2
$85.4M Sell
2,880,119
-283,136
-9% -$8.39M 0.64% 53
2021
Q1
$88.4M Buy
3,163,255
+199,120
+7% +$5.57M 0.66% 47
2020
Q4
$84M Buy
2,964,135
+201,329
+7% +$5.71M 0.65% 55
2020
Q3
$69.5M Sell
2,762,806
-816,905
-23% -$20.5M 0.66% 50
2020
Q2
$87.4M Sell
3,579,711
-210,937
-6% -$5.15M 0.9% 35
2020
Q1
$56.1M Sell
3,790,648
-1,049,988
-22% -$15.5M 0.74% 45
2019
Q4
$78.6M Buy
4,840,636
+8,983
+0.2% +$146K 0.7% 51
2019
Q3
$62.8M Buy
4,831,653
+520,657
+12% +$6.77M 0.63% 57
2019
Q2
$55.9M Buy
4,310,996
+901,779
+26% +$11.7M 0.54% 68
2019
Q1
$53.7M Buy
3,409,217
+1,098,314
+48% +$17.3M 0.51% 65
2018
Q4
$46.5M Buy
2,310,903
+67,248
+3% +$1.35M 0.49% 67
2018
Q3
$55.8M Buy
2,243,655
+439,380
+24% +$10.9M 0.47% 69
2018
Q2
$49.5M Buy
1,804,275
+68,576
+4% +$1.88M 0.45% 78
2018
Q1
$53.5M Sell
1,735,699
-1,035
-0.1% -$31.9K 0.53% 66
2017
Q4
$62.1M Sell
1,736,734
-398,787
-19% -$14.3M 0.63% 57
2017
Q3
$58.8M Buy
2,135,521
+89,659
+4% +$2.47M 0.67% 51
2017
Q2
$54M Buy
2,045,862
+119,000
+6% +$3.14M 0.67% 54
2017
Q1
$40.1M Sell
1,926,862
-91,867
-5% -$1.91M 0.55% 63
2016
Q4
$41.8M Buy
2,018,729
+195,515
+11% +$4.05M 0.66% 50
2016
Q3
$29.6M Buy
1,823,214
+153,222
+9% +$2.48M 0.54% 65
2016
Q2
$22.7M Buy
1,669,992
+535,196
+47% +$7.28M 0.46% 75
2016
Q1
$19.8M Buy
1,134,796
+546,150
+93% +$9.54M 0.44% 79
2015
Q4
$20.1M Buy
588,646
+575
+0.1% +$19.6K 0.55% 59
2015
Q3
$17.5M Buy
588,071
+35,099
+6% +$1.04M 0.48% 65
2015
Q2
$17.7M Sell
552,972
-280,800
-34% -$8.98M 0.43% 67
2015
Q1
$17.3M Buy
833,772
+45,849
+6% +$950K 0.45% 70
2014
Q4
$13.3M Buy
787,923
+85,373
+12% +$1.45M 0.34% 87
2014
Q3
$13.6M Buy
702,550
+269,093
+62% +$5.2M 0.37% 90
2014
Q2
$14.7M Buy
433,457
+413,930
+2,120% +$14.1M 0.42% 88
2014
Q1
$615K Buy
+19,527
New +$615K 0.02% 219